GLP-1 Drugs for Weight Loss and Diabetes - Infographic
With a growing list of available glucagon-like peptide-1 (GLP-1) drugs, it can be confusing to...
Key Takeaways From the HHS’ Prescription Drug Cost Report
The Consolidated Appropriations Act, 2021 (CAA) established consumer protections related to...
New Proposal to Cover Anti-obesity Drugs in Medicare Part D and Medicaid Programs
The Centers for Medicare and Medicaid Services (CMS) has issued a proposed rule that would allow...
Americans Struggling With Drug Prescription Costs
The latest Patient Experience Survey by Pharmaceutical Research and Manufacturers of America...
Deadline Reminder: RxDC Reports Are Due by June 1, 2024
Group health plans and health insurance issuers must annually submit detailed information on...
Eli Lilly Partners With Amazon for Home Delivery of Weight Loss, Diabetic and Other Drugs
Drugmaker Eli Lilly partnered with Amazon Pharmacy to deliver prescriptions sent to its...
Employers Should Start Preparing for 2024 RxDC Reporting
Group health plans and health insurance issuers must annually submit detailed information on...
HHS Releases Updated Drug Data Collection Reporting Instructions in Advance of June 1, 2024, Deadline
Under Section 204 of the Consolidated Appropriations Act, 2021 (CAA), referred to as “The...
Considerations For Evaluating a Pharmacy Benefits Manager
A Pharmacy Benefits Manager (PBM) is an entity that acts as an intermediary between...
Drugmakers Increasing Prices on More Than 500 Drugs in January
Data analyzed by health care research firm 3 Axis Advisors revealed that several pharmaceutical...
FDA Allows First-ever Canadian Drug Imports to the United States
On Jan. 5, 2023, the U.S. Food and Drug Administration (FDA) announced that it will allow Florida...
